Thus, the differential reduction in p11 levels in middle-aged MS animals could be due to CpG methylation of the GR binding site, which prevents GR from easily accessing the p11 promoter, resulting in reduced p11 transcriptional activity. This evidence concerns the gene NR3C1 and myeloid sarcoma.